[go: up one dir, main page]

GB0512278D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB0512278D0
GB0512278D0 GBGB0512278.3A GB0512278A GB0512278D0 GB 0512278 D0 GB0512278 D0 GB 0512278D0 GB 0512278 A GB0512278 A GB 0512278A GB 0512278 D0 GB0512278 D0 GB 0512278D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0512278.3A
Other versions
GB2427194A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Domantis Ltd
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domantis Ltd filed Critical Domantis Ltd
Priority to GB0512278A priority Critical patent/GB2427194A/en
Publication of GB0512278D0 publication Critical patent/GB0512278D0/en
Publication of GB2427194A publication Critical patent/GB2427194A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB0512278A 2005-06-16 2005-06-16 Single domain Helicobacter pylori adhesin antibodies Withdrawn GB2427194A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0512278A GB2427194A (en) 2005-06-16 2005-06-16 Single domain Helicobacter pylori adhesin antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0512278A GB2427194A (en) 2005-06-16 2005-06-16 Single domain Helicobacter pylori adhesin antibodies

Publications (2)

Publication Number Publication Date
GB0512278D0 true GB0512278D0 (en) 2005-07-27
GB2427194A GB2427194A (en) 2006-12-20

Family

ID=34855654

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0512278A Withdrawn GB2427194A (en) 2005-06-16 2005-06-16 Single domain Helicobacter pylori adhesin antibodies

Country Status (1)

Country Link
GB (1) GB2427194A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025880B2 (en) * 2007-03-01 2011-09-27 Helicure Ab Immunoglobulin against Helicobacter pylori

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535321A1 (en) * 1995-09-22 1997-03-27 Max Planck Gesellschaft New adhesive from Helicobacter pylori
US6410719B1 (en) * 1996-06-10 2002-06-25 Thomas Boren Blood group antigen binding protein and corresponding agents
NZ333250A (en) * 1996-06-10 2000-05-26 Thomas Boren Helicobacter pylori blood group antigen binding adhesion protein
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
WO2004081026A2 (en) * 2003-06-30 2004-09-23 Domantis Limited Polypeptides
EP1578801A2 (en) * 2002-12-27 2005-09-28 Domantis Limited Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
WO2005052002A2 (en) * 2003-11-20 2005-06-09 Massachusetts Institute Of Technology Single-domain antibodies and uses thereof

Also Published As

Publication number Publication date
GB2427194A (en) 2006-12-20

Similar Documents

Publication Publication Date Title
IL187106A (en) Sclerostin-binding antibody
IL190472A0 (en) Anti-glypican-3 antibody
IL192266A0 (en) Anti-ilt7 antibody
IL185366A0 (en) Antibody
IL181575A0 (en) Anti-ox40l antibodies
IL228033A0 (en) Antibodies
IL234657A0 (en) P-cadherin antibodies
GB0420466D0 (en) Anti-glucan antibodies
GB0517487D0 (en) Antibodies
EP1869192A4 (en) Framework-shuffling of antibodies
ZA200701952B (en) Anti-OX40L antibodies
IL215527A0 (en) Improved immunoassay methods
EP1896047A4 (en) Anti-gfralpha3 antibodies
EP1780221A4 (en) Anti-synoviolin antibody
GB0505489D0 (en) Antibodies
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
GB0418415D0 (en) Antibody
GB0519883D0 (en) Antibodies
GB0420771D0 (en) Antibody
GB0500400D0 (en) Antibody
GB0402642D0 (en) Antibodies
GB0402641D0 (en) Antibodies
GB0606276D0 (en) Antibodies
GB0607376D0 (en) Antibodies

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)